The Division of Urology has a rich research background from the early inception of the division with a focus on everything from immunology in renal transplantation to improving patient outcomes and risk stratifying patients with urological conditions.

While taking care of the urological conditions of mid-Missourians, the faculty at the University of Missouri also contribute to the larger field of urology, surgery, medicine and wellness through research endeavors. The division has been highly active in publishing manuscripts, presenting projects nationally and internationally and receiving funding for ongoing projects.

Collaborations within the University of Missouri system is highly encouraged and the Division of Urology has embraced this opportunity across the School of Medicine as well as the entire University System. Faculty are directly collaborating with individuals from the following: 

With research goals also comes education of residents and students. Our faculty are proud to mentor and guide these individuals through their own projects from design to final publication. The Division of Urology's faculty and staff have also led several Quality Improvement Projects. These initiatives have been at the forefront in improving the lives and experiences of patients and employees at MU Health Care. The Division of Urology is quite active in medical student education and research involvement, with individuals that rotate on the service and offer a summer urology research fellowship. This instills early research skills and makes for well-rounded physician research leaders for the future. 

Faculty have completed and have ongoing grants and funding opportunities that allow this work to persist. These have been through internal and external mechanisms including PCORI grants, societal grants, institutional grants and pharmaceutical grants.

Faculty have ongoing Clinical Trials that are Investigator-Initiated as well as through Ellis Fischel Cancer Center Clinical Trials Office. The Division of Urology has been very successful in trial recruitment, both for benign urology and oncological diseases, to improve the current and future care of patients.

2022 Publications

Already in 2022, the Division of Urology has been successful with many peer-reviewed publications:

Rosen GH, Nallani A, Muzzey C, and Murray KS. “Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience. J Urol. 2022. doi: 10.1097/JU.00000000000000000002454.

Rosen GH, Davies B, and Murray KS. “Prescribing of Oral Androgen Pathway Directed Medications During the COVID-19 Era.” Urology Practice. 2022. [In Press].

Rosen GH, Kanake S, Golzy M, Malm-Buatsi EM, and Murray KS. “Antimicrobial Selection for Transurethral Procedures Across the United States.” Urology. 2022; 159:107-113. doi: 10.1016/j.urology.2021.10.009.